Coherus Oncology (CHRS) Net Margin Growth (3y) (2016 - 2026)
Coherus Oncology (CHRS) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Coherus Oncology |
199.14 Mn |
32.09 Mn |
8.50 Mn |
22,216.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
22,216.00 |
| Dec 31, 2025 |
19,808.00 |
| Sep 30, 2025 |
26,842.00 |
| Jun 30, 2025 |
342,479.00 |
| Mar 31, 2025 |
3,915.00 |
| Dec 31, 2024 |
-38,845.00 |
| Sep 30, 2024 |
65,556.00 |
| Jun 30, 2024 |
44,138.00 |
| Mar 31, 2024 |
761,344.00 |
| Dec 31, 2023 |
-9,388.00 |
| Sep 30, 2023 |
-7,879.00 |
| Jun 30, 2023 |
-11,907.00 |
| Mar 31, 2023 |
-26,412.00 |
| Dec 31, 2022 |
-16,151.00 |
| Sep 30, 2022 |
-23,508.00 |
| Jun 30, 2022 |
-11,163.00 |
| Mar 31, 2022 |
-10,591.00 |
| Jun 30, 2020 |
413,420.00 |
| Mar 31, 2020 |
4.65 Mn |
| Dec 31, 2019 |
901,618.00 |
